IGF1 and hepatocellular carcinoma: The results of cellular and animal models suggest that the IGF-I signaling pathway plays an important role in the development of hepatocellular carcinoma and clinical trials targeting the IGF-I axis with a focus on the anti-IGF-IR approach have been conducted33.